Prevalence of COPD and tobacco smoking in Malopolska region - Results from the BOLD Study in Poland

Polskie Archiwum Medycyny Wewnetrznej

Volumn 117, Issue 9, 2007, Pages 402-410

  Nizankowska Mogilnicka, Ewa ^a   Mejza, Filip ^a   Buist, A Sonia ^b   Vollmer, William M ^c   Skucha, Wojciech ^d   Harat, Rafal ^e   Pajak, Andrzej ^a   Gasowski, Jerzy ^a   Frey, Jakub ^e   Nastalek, Pawel ^a   Twardowska, Magdalena ^a   Janicka, Joanna ^d   Szczeklik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d District Hospital Proszowice   (Poland)

^e Pulmonary Diseases Ward   (Poland)

Author keywords

COPD; Education level; Poland; Prevalence; Smoking; The BOLD Study

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EDUCATION; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; PREVALENCE; QUESTIONNAIRE; SEX DIFFERENCE; SMOKING; SPIROMETRY;

EID: 36549081883     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.200     Document Type: Article

References (30)

1. European Respiratory Society/ European Lung Foundation. Chronic obstructive pulmonary disease. In: Loddenkemper R, Gibson GJ, Sibille Y, eds. European Lung White Book - the First Comprehensive Survey on Respiratory Health in Europe. Sheffield, ERSJ, 2003: 34-43.
2. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006; 28: 523-532.
3. GOLD Workshop Report 2006: Global Strategy for Diagnosis, Management, and Prevention of COPD. E-published on November 2006; available at GOLD website: http://www.goldcopd.com (accessed May 10, 2007).
4. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004; 364: 613-620.
5. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006; 27: 188-207.
6. Coultas DB, Mapel D, Gagnon RC, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med. 2001; 164: 372-377.
7. Krzyzanowski M, Jedrychowski W, Wysocki M. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow Study. Risk of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986; 134: 1011-1019.
8. Plywaczewski R, Bednarek M, Jonczak L, Zielinski J. Prevalence of COPD in Warsaw population. Pneumonol Alergol Pol. 2003; 71: 329-335.
9. Niepsuj G, Kozielski J, Niepsuj K, et al. Chronic obstructive pulmonary disease in inhabitants of Zabrze. Wiad Lek. 2002; 55: 354-359
10. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003; 123: 1684-1692.
11. Buist AS, Vollmer WM, Sullivan SD, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD. 2005; 2: 277-283.
12. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370: 741-750.
13. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med. 1995; 152: 1107-1136.
14. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999; 159: 179-187.
15. http://www.stat.gov.pl/gus/45_646_PLK_HTML.htm (assessed 17.10.2007).
16. http://www.stat.gov.pl/gus/45_2657_PLK_HTML.htm (assessed 17.10.2007).
17. Schirnhofer L, Lamprecht B, Vollmer WM, et al. COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. Chest. 2007; 131: 29-36.
18. Tzanakis N, Anagnostopoulou U, Filaditaki V, et al. COPD group of the Hellenic Thoracic Society. Prevalence of COPD in Greece. Chest. 2004; 125: 892-900.
19. Lundback B, Lindberg A, Lindstrom M, et al; Obstructive Lung Disease in Northern Sweden Studies. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2003; 97: 115-122.
20. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J. 2003; 22: 268-273.
21. Langhammer A, Johnsen R, Gulsvik A, et al. Sex differences in lung vulnerability to tobacco smoking. Eur Respir J. 2003; 21: 1017-1023.
22. Lindberg A, Jonsson AC, Ronmark E, et al. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest. 2005; 127: 1544-1552.
23. Menezes AM, Perez-Padilla R, Jardim JR, et al. PLATINO Team. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005; 366: 1875-1881.
24. Lokke A, Lange P, Scharling H, et al. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006; 61: 935-939.
25. Hardie JA, Buist AS, Vollmer WM, et al. Risk of over-diagnosis of COPD in asymptomatic elderty never-smokers. Eur Respir J. 2002; 20: 1117-1122.
26. 1/FVC ratio below the fifth percentile, not <70%. Chest. 2007; 131: 349-355.
27. Mannino DM, Buist SA, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax. 2007; 62: 237-241.
28. http://www.stat.gov.pl/gus/45_658_PLK_HTML.htm (accessed 17.10.2007).
29. Zielinski J, Bednarek M and the Know the Age of Your Lung Study Group. Early detection of COPD in a high-risk population using spirometric screening. Chest. 2001; 119: 731-736.
30. Krawczyk K, Skucha W. Incidence of chronic obstructive pulmonary disease among chronic smokers inhabiting Krakow and Proszowice. Przegl Lek. 2000; 57: 617-618.